More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$363816251
EPS
0.37
P/E ratio
25.6
Price to sales
1.35
Dividend yield
--
Beta
1.152756
Previous close
$9.49
Today's open
$9.49
Day's range
$9.33 - $9.57
52 week range
$5.93 - $10.18
show more
CEO
Casey Hoyt
Employees
996
Headquarters
Lafayette, LA
Exchange
NASDAQ Capital Market
Shares outstanding
38336802
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 1Q26
Dallas, Texas--(Newsfile Corp. - May 12, 2026) - Viemed Healthcare, Inc. (NASDAQ: VMD). Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (NASDAQ: VMD).
Newsfile Corp • May 12, 2026

Viemed Healthcare, Inc. (VMD) Q1 2026 Earnings Call Transcript
Viemed Healthcare, Inc. (VMD) Q1 2026 Earnings Call Transcript
Seeking Alpha • May 6, 2026

Viemed Healthcare Announces First Quarter 2026 Financial Results
LAFAYETTE, LA / ACCESS Newswire / May 5, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it has reported its financial results for the three months ended March 31, 2026, and updated guidance for the full year ending December 31, 2026. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended March 31, 2026 were $75.4 million, representing an increase of $16.3 million, or 28%, over net revenues reported for the comparable quarter ended March 31, 2025.
Accesswire • May 5, 2026

Viemed Healthcare, Inc. (VMD) Q1 Earnings Miss Estimates
Viemed Healthcare, Inc. (VMD) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.06 per share a year ago.
Zacks Investment Research • May 6, 2026

Viemed Healthcare Announces First Quarter 2026 Earnings Conference Call Details
LAFAYETTE, LA / ACCESS Newswire / April 21, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that it will host its First Quarter 2026 Earnings Conference Call on Wednesday, May 6, 2026, at 11:00 a.m. EDT. Interested parties may participate in the call by dialing: 877-407-6176 (US Toll-Free) +1 201-689-8451 (International) Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=MWjE55eM Following the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com.
Accesswire • Apr 21, 2026

Viemed Healthcare to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19
LAFAYETTE, LA / ACCESS Newswire / March 16, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced it will present and host one-on-one meetings with investors at Sidoti's Small-Cap Virtual Investor Conference, taking place on March 18-19, 2026. The presentation will begin at 1:45 p.m.
Accesswire • Mar 16, 2026

Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 4Q 2025
Dallas, Texas--(Newsfile Corp. - March 11, 2026) - Viemed Healthcare, Inc. (NASDAQ: VMD). Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (NASDAQ: VMD).
Newsfile Corp • Mar 11, 2026

Viemed Healthcare, Inc. (VMD) Q4 2025 Earnings Call Transcript
Viemed Healthcare, Inc. (VMD) Q4 2025 Earnings Call Transcript
Seeking Alpha • Mar 5, 2026

Viemed Healthcare Announces 2026 Share Repurchase Program
LAFAYETTE, LA / ACCESS Newswire / March 4, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that its Board of Directors has authorized a share repurchase program effective through March 2027. Under the share repurchase program, which constitutes a normal course issuer bid under applicable Canadian securities laws, Viemed may purchase up to 1,930,131 common shares of the Company ("the Common Shares") from time to time in accordance with applicable securities laws, representing approximately 5% of the total issued and outstanding Common Shares as of March 4, 2026.
Accesswire • Mar 4, 2026

Viemed Healthcare Announces Record 2025 Financial Results
LAFAYETTE, LA / ACCESS Newswire / March 4, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it has reported its financial results for the three months and year ended December 31, 2025, and issued its guidance for the full year ending December 31, 2026. Fourth Quarter and Full Year Operational Highlights (all dollar amounts are USD): Net revenues for the quarter ended December 31, 2025 were a company record $76.2 million, an increase of $15.5 million, or 26%, over net revenues reported for the comparable quarter ended December 31, 2024.
Accesswire • Mar 4, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Viemed Healthcare Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.